BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 4678590)

  • 1. [LATS and infiltrating ocular changes in Graves-Basedow's disease].
    Nauman J; Nauman A
    Pol Arch Med Wewn; 1972 Dec; 49(6):597-606. PubMed ID: 4678590
    [No Abstract]   [Full Text] [Related]  

  • 2. [Etiology of Basedow's disease, with special reference to LATS].
    Nagata K
    Naika Hokan; 1969 Jul; 16(7):297-317. PubMed ID: 4901097
    [No Abstract]   [Full Text] [Related]  

  • 3. [Study of the relationship between Basedow's disease and Hashimoto thyroiditis].
    Földes J; Takó J; Bános C; Gesztesi E; Juhász J
    Orv Hetil; 1971 Apr; 112(17):968-71. PubMed ID: 5108752
    [No Abstract]   [Full Text] [Related]  

  • 4. [Ocular symptoms in Basedow's disease].
    Shishiba Y
    Nihon Rinsho; 1971 May; 29(5):1320-3. PubMed ID: 5108758
    [No Abstract]   [Full Text] [Related]  

  • 5. [Development of serum LATS activity in some cases of Basedow's disease treated with corticoids or immunodepressants].
    Linquette M; Fossati P; Decoulx M; Hubschman B
    Ann Endocrinol (Paris); 1968; 29(6):731-9. PubMed ID: 5757239
    [No Abstract]   [Full Text] [Related]  

  • 6. [Familial Basedow's disease in 3 generations].
    Gilbert-Dreyfus ; Peillon F; Doucet D
    Ann Med Interne (Paris); 1972 Nov; 123(11):937-40. PubMed ID: 4679054
    [No Abstract]   [Full Text] [Related]  

  • 7. [Long-acting thyroid stimulator (LATS), thyrotropin (TSH) and the pathogenesis of hyperthyroidism].
    Lamberg BA; Gordin A
    Nord Med; 1968 Dec; 80(49):1651-7. PubMed ID: 5757398
    [No Abstract]   [Full Text] [Related]  

  • 8. [Simultaneous study of LATS and antimicrosomial antibodies in untreated Basedow's disease].
    Orgiazzi J; Pousset G; Durand H
    Presse Med (1893); 1971 May; 79(25):1167-8. PubMed ID: 4933634
    [No Abstract]   [Full Text] [Related]  

  • 9. [L.A.T.S. activity during hyperthyroidism. Apropos of 143 cases of Basedow's disease].
    Letonturier P; Tourneur R; Sénécal P
    Ann Med Interne (Paris); 1974 May; 125(5):463-7. PubMed ID: 4140703
    [No Abstract]   [Full Text] [Related]  

  • 10. [ON THE THYROID STIMULATING ACTION OF BLOOD PLASMA FROM PATIENTS WITH BASEDOW'S DISEASE. (THE "LONG ACTING THYROID STIMULATOR" TEST IN BASEDOW'S DISEASE)].
    FOELDES J; KRASZNAI I; GYERTYANFFY G
    Orv Hetil; 1965 May; 106():883-6. PubMed ID: 14305014
    [No Abstract]   [Full Text] [Related]  

  • 11. [Hyperthyroidism and the "long acting thyroid stimulator" (LATS)].
    Studer H
    Schweiz Med Wochenschr; 1967 May; 97(19):622-3. PubMed ID: 5632362
    [No Abstract]   [Full Text] [Related]  

  • 12. [LATS and Graves' disease].
    Gordon A
    Harefuah; 1971 May; 80(10):569-70. PubMed ID: 5171988
    [No Abstract]   [Full Text] [Related]  

  • 13. [Thyreotropic function of the blood in Basedow's disease in puberty].
    Földes J; Barta L; Büki B; Tamás G; Gesztes E
    Acta Paediatr Acad Sci Hung; 1969; 10(2):123-32. PubMed ID: 4189492
    [No Abstract]   [Full Text] [Related]  

  • 14. [Abnormality and deficiency in cellular immunity and internal diseases--Basedow's disease and cellular immunity].
    Shishiba Y
    Nihon Rinsho; 1978; 36(5):960-6. PubMed ID: 353330
    [No Abstract]   [Full Text] [Related]  

  • 15. Correlation of long-acting thyroid stimulator with serum levels of tri-iodothyronine, thyroxine and thyrotropin in Graves' disease.
    Sawhney RC; Kannan V; Rastogi GK
    J Assoc Physicians India; 1975 Feb; 23(2):111-4. PubMed ID: 1242389
    [No Abstract]   [Full Text] [Related]  

  • 16. [Etiology of Basedow's disease].
    Kumahara U; Fukuchi M
    Horumon To Rinsho; 1967 Oct; 15(10):834-40. PubMed ID: 4870889
    [No Abstract]   [Full Text] [Related]  

  • 17. Long-acting thyroid stimulator (LATS) in toxic nodular goitre, toxic adenoma and Graves' disease.
    Lamberg BA; Gordin A; Viherkoski M; Kvist G
    Acta Endocrinol (Copenh); 1969 Oct; 62(2):199-209. PubMed ID: 5394703
    [No Abstract]   [Full Text] [Related]  

  • 18. [Standardization of the radiobiological method for determination of long-acting thyroid stimulator (LATS) in human serum].
    Muramoto E; Nicolau W; Ikeda E; de Assis LM; Pieroni RR
    AMB Rev Assoc Med Bras; 1972 Oct; 18(10):379-88. PubMed ID: 4539360
    [No Abstract]   [Full Text] [Related]  

  • 19. Absence of thyroid-stimulating antibody and long acting thyroid stimulator in relatives of Graves' disease patients.
    Banovac K; Zakarija M; McKenzie JM; Witte A; Sekso M
    J Clin Endocrinol Metab; 1981 Sep; 53(3):651-3. PubMed ID: 6790561
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [LATS in Graves-Basedow disease].
    Nauman J; Nauman A
    Pol Arch Med Wewn; 1971; 46(3):315-21. PubMed ID: 5108058
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.